Skip to main content
Log in

Verapamil and norverapamil in plasma and breast milk during breast feeding

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The concentrations of verapamil and norverapamil have been measured in milk and plasma samples from a 32year-old woman treated with verapamil 80 mg tds while breast-feeding her child.

The average steady-state concentrations of verapamil and norverapamil in milk were, respectively, 60% and 16% of the concentrations in plasma.

The breast-fed child received less than 0.01% of the dose of verapamil given to the mother. No verapamil or norverapamil (<1 ng/ml) could be detected in the plasma from the child.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schomerus M, Spiegelhalder B, Stieren B, Eichelbaum M (1976) Physiological disposition of verapamil in man. Cardiovasc Res 10: 605–612

    Google Scholar 

  2. Eichelbaum M, Somogyi A, von Unruh GE, Dengler HJ (1981) Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil. Eur J Clin Pharmacol 19: 133–137

    Google Scholar 

  3. McAllister Jr RG, Kirsten EB (1982) The pharmacology of verapamil IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin. Pharmacol Ther 31: 413–426

    Google Scholar 

  4. Kates RE, Keefe DLD, Schwartz J, Harapat S, Kirsten EB, Harrison DC (1981) Verapamil disposition kinetics in chronic atrial fibrillation. Clin Pharmacol Ther 30: 44–51

    Google Scholar 

  5. Anderson P, Bondesson U, Sylven C (1982) Clinical pharmacokinetics of verapamil in patients with atrial fibrillation. Eur J Clin Pharmacol 23: 49–57

    Google Scholar 

  6. Freedman SB, Richmond DR, Ashley JJ, Kelly DT (1981) Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clin Pharmacol Ther 30: 644–652

    Google Scholar 

  7. Eichelbaum M, Dengler HJ, Somogyi A, von Unruh GE (1981) Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Eur J Clin Pharmacol 19: 127–131

    Google Scholar 

  8. Schwartz JB, Keefe DL, Kirstein E, Kates RE, Harrison DC (1982) Prolongation of verapamil elimination kinetics during chronic oral administration. Am Heart J 104: 198–203

    Google Scholar 

  9. Shand DG, Hammill SC, Aanonsen L, Pritchett ELC (1981) Reduced verapamil clearance during long-term oral administration. Clin Pharmacol Ther 30: 701–703

    Google Scholar 

  10. Inoue H, Unno N, Ou MC et al. (1983) Excretion of verapamil in human milk. Br Med J 287: 1596

    Google Scholar 

  11. de Swiet M (1984) Excretion of verapamil in human milk. Br Med J 288: 644–645

    Google Scholar 

  12. Andersen HJ (1983) Excretion of verapamil in human milk. Eur J Clin Pharmacol 25: 279–280

    Google Scholar 

  13. Inoue H, Unno N, Ou M-C, Iwama Y, Sugimoto T (1984) Level of verapamil in human milk. Eur J Clin Pharmacol 26: 657–658

    Google Scholar 

  14. Miller MR, Withers R, Bhamra R, Holt DW (1986) Verapamil and breast-feeding. Eur J Clin Pharmacol 30: 125–126

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, P., Bondesson, U., Mattiasson, I. et al. Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur J Clin Pharmacol 31, 625–627 (1987). https://doi.org/10.1007/BF00606644

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606644

Key words

Navigation